Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John Swain is active.

Publication


Featured researches published by John Swain.


Archive | 2001

Cyclohexylderivate und ihre anwendung als therapeutische mittel Cyclohexyl derivatives and their use as therapeutic agents

Pineiro Luis Jose Harlow Castro; Kevin Harlow Dinnell; Matthew Jason Harlow Elliott; John Gregory Harlow Hollingworth; Edward Duncan Harlow Shaw; John Swain


Archive | 2000

Tetrahydropyranderivate und deren verwendung als therapeutische mittel Tetrahydropyran derivatives and their use as therapeutic agents

Neil Owen; Mary Seward; John Swain; John W. Williams


Archive | 1997

Use of NK-1 receptor antagonists for the treatment of major depression

Roy Neil Harlow Curtis; Matthew Jason Harlow Elliott; Timothy Harrison; John Gregory Harlow Hollingworth; Stephen Philip Harlow Jackson; Jozef Janusz Harlow Kulagowski; Melanie Nadia Harlow Rupniak; Mary Seward; John Swain; John Brian Harlow Williams


Archive | 1997

The use of nk-1 receptor antagonists for the treatment of substance-use disorders

Raymond Baker; Roy Neil Harlow Curtis; Matthew Jason Harlow Elliott; Timothy Harrison; John Gregory Harlow Hollingworth; Stephen Philip Harlow Jackson; Jozef Janusz Harlow Kulagowski; Melanie Nadia Harlow Rupniak; Mary Seward; John Swain; John Brian Harlow Williams


Archive | 1997

Verwendung von nk-1 rezeptorantagonisten zur behandlung von schweren depressionen, die von angstzuständen begleitet werden Use of nk-1 receptor antagonists for the treatment of severe depression accompanied by anxiety states

Roy Neil Harlow Curtis; Matthew Jason Harlow Elliott; Timothy Harrison; John Gregory Harlow Hollingworth; Stephen Philip Harlow Jackson; Jozef Janusz Harlow Kulagowski; Melanie Nadia Harlow Rupniak; Mary Seward; John Swain; John Brian Harlow Williams


Archive | 1997

Die verwendung von nk-1 rezeptor antagonisten für die behandlung von bewegungsstörungen The use of NK-1 receptor antagonists for the treatment of movement disorders

Raymond Baker; Roy Neil Harlow Curtis; Matthew Jason Harlow Elliott; Timothy Harrison; John Gregory Harlow Hollingworth; Stephen Philip Harlow Jackson; Jozef Janusz Harlow Kulagowski; Melanie Nadia Harlow Rupniak; Mary Seward; John Swain; John Brian Harlow Williams


Archive | 1997

Die verwendung von nk-1 rezeptorantagonisten für die behandlung von kognitiven störungen The use of NK-1 receptor antagonists for the treatment of cognitive disorders

Roy Neil Harlow Curtis; Matthew Jason Harlow Elliott; Timothy Harrison; John Gregory Harlow Hollingworth; Stephen Philip Harlow Jackson; Jozef Janusz Harlow Kulagowski; Melanie Nadia Harlow Rupniak; Mary Seward; John Swain; John Brian Harlow Williams


Archive | 1997

Die verwendung von nk-1 rezeptor antagonisten für die behandlung von substanz-verwendung störungen The use of NK-1 receptor antagonists for the treatment of substance use disorders

Raymond Baker; Roy Neil Harlow Curtis; Matthew Jason Harlow Elliott; Timothy Harrison; John Gregory Harlow Hollingworth; Stephen T. Jackson; Jozef Janusz Harlow Kulagowski; Melanie Nadia Harlow Rupniak; Mary Seward; John Swain; John W. Williams


Archive | 1995

Morpholinderivate und ihre verwendung als therapeutische mittel Morpholine derivatives and their use as therapeutic agents

Timothy Harrison; Pate Owens; John Swain


Archive | 1995

Aralkoxy und aralkylthio substituierte azacyclische verbindungen als tachykinin antagonisten Antagonists Aralkoxy and Aralkylthio substituted azacyclic compounds as tachykinin

Raymond Baker; Murray Macleod; Mary Seward; John Swain

Collaboration


Dive into the John Swain's collaboration.

Top Co-Authors

Avatar

John W. Williams

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

Stephen T. Jackson

United States Geological Survey

View shared research outputs
Researchain Logo
Decentralizing Knowledge